Modulators of cystic fibrosis transmembrane conductance regulator

Details for Australian Patent Application No. 2008335031 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Grootenhuis, Peter D.J.; Binch, Hayley; Pierce, Albert; Fanning, Lev T.D.

Agent Baldwins

Pub. Number AU-A-2008335031

PCT Pub. Number WO2009/076593

Priority 61/013,336 13.12.07 US

Filing date 12 December 2008

Wipo publication date 18 June 2009

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 1/18 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

8 July 2010 PCT application entered the National Phase

  PCT publication WO2009/076593 Priority application(s): WO2009/076593

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008335032-Bone/collagen composites and uses thereof

2008335029-Antiperspirant active compositions having SEC chromatogram exhibiting high SEC Peak 4 intensity